Previous Article | Next Article 
Infection and Immunity, August 1999, p. 4106-4111, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Purification and Properties of Proline-Rich
Antimicrobial Peptides from Sheep and Goat Leukocytes
Olga
Shamova,1,2
Kim A.
Brogden,3
Chengquan
Zhao,1
Tung
Nguyen,1
Vladimir N.
Kokryakov,1 and
Robert
I.
Lehrer1,4,*
Department of
Medicine1 and Molecular Biology
Institute,4 UCLA School of Medicine, Los
Angeles, California 90095; Department of General Pathology and
Pathophysiology, Institute for Experimental Medicine, 19736 St.
Petersburg, Russia2; and Respiratory and
Neurologic Diseases Research Unit, Midwest Area National Animal
Disease Center, Agricultural Research Service, U.S. Department of
Agriculture, Ames, Iowa 500103
Received 18 March 1999/Returned for modification 11 May
1999/Accepted 19 May 1999
 |
ABSTRACT |
We purified three proline-rich antimicrobial peptides from
elastase-treated extracts of sheep and goat leukocytes and subjected two of them, OaBac5
and ChBac5, to detailed analysis. OaBac5
and
ChBac5 were homologous to each other and to bovine Bac5. Both exhibited
potent, broad-spectrum antimicrobial activity under low-concentration
salt conditions. While the peptides remained active against
Escherichia coli, Pseudomonas aeruginosa,
Bacillus subtilis, and Listeria monocytogenes
in 100 mM NaCl, they lost activity against Staphylococcus
aureus and Candida albicans under these conditions.
ChBac5 was shown to bind lipopolysaccharide, a property that could
enhance its ability to kill gram-negative bacteria. Proline-rich Bac5
peptides are highly conserved in ruminants and may contribute
significantly to their innate host defense mechanisms.
 |
INTRODUCTION |
Various antimicrobial peptides
enhance the ability of mammalian neutrophils to overcome microbial
incursions (5, 12). Among these are cathelicidins
(31), propeptides containing a highly conserved N-terminal
"cathelin" domain (17) and a C-terminal domain with
antimicrobial properties. The secondary (specific) granules of human
neutrophils contain a single cathelicidin, hCAP-18, the precursor of an
-helical antimicrobial peptide called LL-37 (7, 26). In
contrast, bovine neutrophils contain many cathelicidins (31), including molecules whose antimicrobial domains encode a cyclic dodecapeptide (18), a tryptophan-rich
tridecapeptide, indolicidin (2, 21), proline- and
arginine-rich Bac5 and Bac7 peptides (4), and several
-helical peptides (20, 24, 29). Many of these peptides
have been well studied at the peptide level.
There is cDNA evidence (1, 9, 13) for at least eight
cathelin-associated peptides in the sheep; however, relatively little
is known about their antimicrobial properties. We treated leukocyte
extracts from sheep (Ovis aries) and goats (Capra
hirca) with neutrophil elastase to generate antimicrobial moieties
from their cathelicidin precursors. This report describes the
purification, compositions, and antimicrobial properties of two
proline-rich antimicrobial peptides, ovine (Oa)Bac5
and caprine (Ch)Bac5.
 |
MATERIALS AND METHODS |
Preparation of leukocytes.
With institutional approval, 250 to 300 ml of venous blood was obtained from healthy sheep and goats and
anticoagulated with citrate. Leukocytes were prepared by lysing the
erythrocytes with 0.83% ammonium chloride (2 cycles), followed by
brief exposure to cold 0.22% saline. Goat leukocyte preparations
contained 80.2% ± 2.4% neutrophils (mean ± standard error of
the mean; n = 10), and sheep preparations contained
77.3% ± 4.0% neutrophils (n = 12). The final number
of neutrophils obtained per collection was (1.18 ± 0.14) × 109 from goats and (0.74 ± 0.12) × 109 from sheep (mean ± standard error of the mean).
Purification of OaBac5
and ChBac5.
Initially, we
attempted to purify neutrophil antimicrobial peptides from phorbol
myristate acetate (PMA)-induced leukocyte secretions, but this approach
yielded insufficient amounts of processed cathelicidins. Consequently,
we generated the peptides described in this report by treating extracts
of goat and sheep leukocytes with human neutrophil elastase (ART
Biochemicals, Athens, Ga.), essentially as described by Panyutich et
al. (15). Briefly, leukocytes were centrifuged at
225 × g for 10 min, resuspended in 10% acetic acid,
sonicated, and extracted overnight at 0 to 4°C. The extracts were
clarified at 3,000 × g for 30 min at 4°C, and the
supernatants were lyophilized for storage. This material was dissolved
in 0.1 M Tris-0.15 M NaCl buffer (pH 7.5) and treated with 1.5 to 2.0 µg of elastase/mg of protein for 30 min at 37°C. Proteolysis was
stopped by adding acetic acid to a final concentration of 5%. After
passage through a YM-10 filter (Amicon, Beverly, Mass.), the
ultrafiltrates were concentrated by vacuum centrifugation and desalted
on a Sep-Pak light C18 cartridge (Waters Millipore, Milford, Mass.). The recovered material was dried, resuspended in 1 ml
of 0.5% acetic acid containing 3 M urea, and subjected to preparative
continuous electrophoresis (8). Fractions containing 3- to
5-kDa peptides were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), pooled, and purified by reversed-phase high-pressure liquid chromatography (RP-HPLC) on a Vydac
C18 column by using linear gradients of 0 to 60%
acetonitrile in 0.1% trifluoroacetic acid or 0.13% hexafluorobutyric acid.
Biochemical analyses.
Purified goat and sheep peptides or
secretates were analyzed by MALDI and/or ESI mass spectrometry. Amino
acid sequences were determined by gas-phase Edman degradation with a
Porton Model 2090E instrument by using 300 to 500 pmols of purified
peptide. Protein concentrations were measured by the bicinchoninic acid procedure (Pierce, Rockford, Ill.).
cDNA cloning.
Bone marrow was obtained from a young male
goat, and a custom cDNA library was constructed in a Uni-ZAP XR vector
(Stratagene, La Jolla, Calif.). The P1 sense primer
5'-GCTAATCTCTACCGCCTCCTGG-3' (nucleotides [nt] 168 to 189 of BtBac5) and P2 antisense primer 5'-CCACACACTGTTTCACCAGCC-3'
(nt 319 to 339 of BtBac5) were derived from a conserved sequence
of bovine Bac5 cDNA (32). To obtain 5' side sequences, we
used P2 and the vector SK primer to amplify goat bone marrow cDNA. To
get 3' side sequences, P1 and vector primer T7 were used. There was a
172-bp sequence overlap between the two PCR products. The amplified PCR
products were cloned into PCR2.1-TOPO vector (Invitrogen, Carlsbad,
Calif.), sequenced by the fluorescein-labeled dideoxynucleotide
termination method, and analyzed on an ABI-373 Sequencer (Perkin-Elmer,
Palo Alto, Calif.).
Western blots.
A rabbit polyclonal antibody against porcine
cathelin (23) was obtained from Jishu Shi and Tomas Ganz of the
University of California, Los Angeles, and was found to react with goat
and sheep cathelins. Goat anti-rabbit immunoglobulin G conjugated to
alkaline phosphatase was purchased from Bio-Rad (Hercules, Calif.).
SDS-PAGE gels of neutrophil extracts were electrotransferred to
Immobilon-P membranes (Millipore, Bedford, Mass.). The membranes were
blocked for 1 h with 3% gelatin and 1% bovine serum albumin in
0.5 M NaCl and 20 mM Tris, pH 7.5, and then washed with 0.05% Tween 20 in 0.5 M NaCl and 20 mM Tris, pH 7.5. The membranes were probed with
anticathelin antibody (1:1,000), washed, and then probed with a second
antibody (1:500). A mixture of 5-bromo-4-chloro-3-indolylphosphate (BCIP) and nitroblue tetrazolium in a solution of 100 mM NaCl, 5 mM
MgCl2, and 100 mM Tris (pH 9.8) was used for color development.
Antibacterial assays.
The peptides were tested for
antimicrobial activity against Escherichia coli ML-35,
Salmonella typhimurium 14028S, Pseudomonas aeruginosa MR 3007, Listeria monocytogenes EGD,
Bacillus subtilis, Staphylococcus aureus
930918-3, and Candida albicans 820 by a two-stage radial
diffusion technique (27). Briefly, approximately 4 × 106 CFU of mid-logarithmic-phase organisms were dispersed
in a 10-ml volume of underlay gel that contained 10 mM sodium
phosphate, 0.3 mg of trypticase soy broth powder (Difco, Detroit,
Mich.) per ml, and 1% (wt/vol) agarose (Sigma A6013) with or
without 100 mM NaCl. Peptide concentrations were established by
quantitative amino acid analysis. Serial peptide dilutions were
prepared in 0.01% acetic acid containing 0.1% human serum albumin,
and 8-µl peptide samples were applied. Overlay gels (10 ml of
trypticase soy agar, 60 g/liter) were poured 3 h after the peptide
samples were added. The clear zones were measured to the nearest 0.1 mm after overnight incubation and were expressed in units (1 mm = 10 U) after subtracting the well diameter. Dose response studies were also
performed by conventional colony counting.
In radial diffusion assays, the MIC is defined by the x
intercept of a regression line through zone diameters obtained from a
series of serially diluted peptide samples. An
-defensin, NP-1, purified from the leukocytes of rabbits was used as a control. The
experiments were performed under low and high concentrations of salt.
In low concentrations of salt, the underlay gels contained 10 mM sodium
phosphate buffer without added NaCl (pH 7.4). For high concentrations
of salt, underlay gels also contained 10 mM sodium phosphate buffer
plus 100 mM NaCl.
LPS binding.
Peptides of interest were dried in 1.5-ml
sterile polypropylene microcentrifuge tubes by vacuum centrifugation
and were resuspended in endotoxin-free, 0.01% acetic acid. Polymyxin B
(7,600 U/mg) (Sigma) was used as a positive control. Assays were
performed in flat-bottom 96-well tissue culture plates (catalog no.
3596; Costar, Cambridge, Mass.) with a Quantitative Chromogenic Lysate kit (Bio Whittaker, Walkersville, Md.) as previously described (30). Standard curves generated with graded amounts of
lipopolysaccharide (LPS) were linear between 0.5 and 0.0625 endotoxin
units (EU)/assay (r = 0.997); consequently LPS binding
was assumed to be proportional to the inhibition of procoagulant activation.
 |
RESULTS |
Peptide purification.
SDS-PAGE of acetic acid extracts of
untreated goat and sheep leukocytes revealed a paucity of peptides
smaller than 7 to 8 kDa (Fig. 1),
suggesting that 3- to 4.5-kDa defensins were absent. Multiple 15- to
19-kDa peptide species that reacted with an anticathelin antibody were
present in both species (data not shown). Because bovine cathelicidins
are processed by neutrophil elastase (19), we used this
enzyme (15) to treat goat and sheep cathelicidins in vitro.
Figure 1 also shows the elastase-processed components of goat and sheep
neutrophils and the purified Bac5 peptides described in this report.
Figure 2 shows stages in the purification
of OaBac5
, one of the peptides described in this report.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE gel. The lanes contain the following: 1, mass
standards; 2, acid extract of goat leukocytes (45 µg of protein); 3, goat leukocyte extract, post-elastase treatment (25 µg of protein);
4, purified ChBac5 (1 µg of protein); 5, acid extract of sheep
leukocytes (45 µg of protein); 6, sheep leukocyte extract,
post-elastase treatment (25 µg of protein); and 7, purified OaBac5
(1 µg of protein). The gel was stained with Coomassie blue.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
Purification of OaBac5 . The inset photographs are of
silver-stained SDS-PAGE gels. Photograph a shows the composition of
fractions 21 to 25, obtained after continuous preparative
electrophoresis (8). The masses of two standards (3.0 and
6.2 kDa; Std) are shown. The main figure shows a chromatogram of the
RP-HPLC purification of electrophoretic fractions 22 and 23. Note the
prominent peak (OaBac5 ) that emerged at approximately 34%
acetonitrile. Photograph b shows this peak.
|
|
Quantitative aspects of the process were as follows. A crude acetic
acid extract from 3 × 10
9 sheep leukocytes contained
31.2 mg of protein, representing 15.6%
of the extract's dry weight.
After elastase cleavage, approximately
two-thirds of the protein (19.8 mg) was recovered in the YM-10
filtrate. Of this, we recovered 3 mg of
protein by eluting the
Sep-Pak cartridge with 60% acetonitrile.
Subjecting this material
to preparative electrophoresis followed by
three cycles of RP-HPLC
yielded 45 to 50 µg of highly purified ovine
OaBac5

. Handled
in the same manner, 1.3 × 10
9 goat
leukocytes (12.2 mg of total protein) yielded approximately
30 µg of
highly purified ChBac5. Our largest-scale purification
of goat Bac5
began with 407 mg of total protein and yielded 229
µg of highly
purified
ChBac5.
Characterization and cDNA cloning of ChBac5.
By using
primers derived from bovine Bac5 cDNA and vector to amplify a goat bone
marrow cDNA library, we obtained the full cDNA sequence of ChBac5
(Fig. 3). The 528-nt open reading frame predicted a 176-residue prepropeptide with a 29-residue
signal sequence. The cDNA sequence corresponding to mature ChBac5
was at the 3' end of the open reading frame. Its deduced
sequence matched the amino acid sequence determined at the peptide
level. The 46-residue (postcathelin) peptide encoded in goat
cDNA had a calculated molecular mass of 5,531.6 Da. Since our
purified peptide had a measured mass of 5,160.2 Da, we concluded that
it was a 43-residue amidated form (calculated mass, 5,161.2 Da). Overall, 40 of the 46 (87%) residues in goat ChBac5-GRR were
identical to those in bovine Bac5-GRR, and another 4 of the 46 (8.7%)
represented conservative substitutions (Fig.
4).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
cDNA and deduced amino acid sequences of ChBac5. All
boldface and underlined amino acid residues were confirmed by
peptide-level sequencing, with the exception of the arginine residue in
parentheses. The arrow shows the putative cleavage site for the signal
peptide. The predicted sequence of mature ChBac5 is shown in bold type,
and the stop codon is marked by asterisks. Our peptide-level mass
measurements indicated that the C-terminal GRR residues are removed,
presumably when the peptide undergoes amidation.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Amino acid sequences of Bac5 peptides. Row a compares
the sequences of goat ChBac5 and bovine BtBac5 (4). Rows b
and c show the N-terminal sequences of ovine Bac5 and - ,
determined at the peptide level, with the differences in boldface. X
signifies an unidentified residue. Row d shows the inferred sequence of
prepro-OaBac5, as described by Huttner et al. (9). Below
this is the N-terminal sequence of OaBac5 as determined in this
study. Identical residues are connected with lines.
|
|
Figure
4 compares the N-terminal peptide sequence of ovine OaBac5

to
the OaBac5 sequence established by cloning (
9). All
of the
N-terminal residues identified by peptide sequencing corresponded
to
those encoded by the cDNA. The 46-residue postcathelin peptide
encoded
in ovine OaBac5 cDNA had a calculated mass of 5,539.7
Da, whereas an
amidated peptide that contained 43 residues and
lacked the C-terminal
GRR should have a mass of 5,169.3 Da. Since
the measured mass of
purified OaBac5

peptide was 5,157.5 Da,
OaBac5

was probably a
43-residue amidated variant of OaBac5 with
a primary sequence that
diverged from that encoded in the cDNA
in at least one residue. We
obtained experimental evidence for
further heterogeneity of ovine Bac5
by isolating an additional
peptide, OaBac5

, in the processed sheep
leukocyte extracts (Fig.
4). OaBac5

was approximately 20 to 30% as
abundant as OaBac5

,
differed from it in 2 of 17 corresponding
residues that were defined
by N-terminal sequencing, and was 38 Da
smaller. OaBac5

was antimicrobial,
but we lacked sufficient
quantities for extensive
testing.
PMA-induced secretions.
We stimulated goat neutrophils (5 × 107 cells/ml) with 1 µg of PMA per ml and examined the
supernatants for cathelicidin precursors and processed antimicrobial
peptides. Precursors were recognized by their apparent molecular mass
on SDS-PAGE gels and by their reactivity with antibody against
cathelin. Consonant with earlier studies on bovine neutrophils
(32), goat secretates contained mostly intact cathelicidin
precursors. However, when the secreted material was subjected to
RP-HPLC, we detected trace amounts of a 5,160-Da molecule by analyzing
HPLC fractions that eluted at between 34 and 36% acetonitrile (data
not shown).
Antimicrobial activity.
Because limited amounts of
OaBac5
and ChBac5 were available for study, we used a
two-stage radial diffusion assay for most studies (11, 27,
30). Under low concentrations of salt, the MICs of each peptide
against E. coli ML-35p and L. monocytogenes EGD
were less than 2.5 µg/ml (Fig. 5a and
b). OaBac5
and ChBac5 appeared slightly more potent than rabbit
defensin NP-1. High concentrations of salt reduced the activity of NP-1
against E. coli (MIC
25 µg/ml) without affecting its potency against L. monocytogenes (Fig. 5c and d). High concentrations of salt did not
impair the activities of OaBac5
and ChBac5 against either organism.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 5.
Activity against E. coli and L. monocytogenes. The antimicrobial activities of OaBac5 ,
ChBac5, and rabbit defensin NP-1 were measured in radial diffusion
assays against E. coli ML-35p (a and c) and L. monocytogenes EGD (b and d). The tests were performed under low (a
and b) and high (c and d) concentrations of salt, as described in
the text. The x intercepts of the least mean square
regression lines through the respective data points define the minimal
inhibitory concentration.
|
|
Under low concentrations of salt, OaBac5

, ChBac5, and NP-1 had
approximately equal activity against
P. aeruginosa, with
MICs
less than 2 µg/ml (Fig.
6b). The
presence of 100 mM NaCl had little
effect on OaBac5

or ChBac5
but decreased the activity of NP-1
considerably (Fig.
6d). ChBac5
was also active against two other
strains of
P. aeruginosa
derived from patients with cystic fibrosis.
The MICs for a highly
mucoid strain were 1.2 and 5.2 µg/ml in
the media containing low and
high concentrations of salt, respectively.
The MICs for the other
strain were 0.5 and 3.6 µg/ml in these
respective media.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 6.
Activity against S. typhimurium and P. aeruginosa. The antimicrobial activities of OaBac5 , ChBac5,
and rabbit defensin NP-1 were measured in radial diffusion assays
against S. typhimurium 14028S (a and c) and P. aeruginosa (b and d). The tests were performed under low (a and b)
and high (c and d) concentrations of salt, as described in the text.
The x intercepts of the least mean square regression lines
through the data points define the minimal inhibitory concentration.
|
|
Figure
6a and c show that NP-1 was active against
S. typhimurium 14028S under low concentrations of salt (MIC < 1 µg/ml) but
lost efficacy in 100 mM NaCl (MIC > 100 µg/ml). In
contrast, OaBac5
was equally active (MIC < 1 µg/ml)
against
S. typhimurium under
both sets of conditions,
but ChBac5 showed reduced activity (MIC
= 10 µg/ml) in
high concentrations of
salt.
Figure
7 shows that NP-1 and both Bac5
peptides killed
B. subtilis effectively under low
(MIC = 1 to 2 µg/ml) and high concentrations
of salt (MIC = 0.3 to 0.75 µg/ml). NP-1 retained activity (MIC
= 1.5 µg/ml)
against
S. aureus in 100 mM NaCl, but OaBac5

and
ChBac5 were inactive under these conditions. OaBac5

, ChBac5,
and NP-1 were effective against
C. albicans (MIC = 1.5 to 3 µg/ml)
under low concentrations of salt but not in 100 mM NaCl
(MIC >
100 µg/ml) (data not shown).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 7.
Activity against S. aureus and B. subtilis. The antimicrobial activities of OaBac5 , ChBac5,
and rabbit defensin NP-1 were measured in radial diffusion assays
against S. aureus (a and c) and B. subtilis (b
and d). The tests were performed under low (a and b) and high (c and d)
concentrations of salt, as described in the text. The x
intercepts of the least mean square regression lines through the data
points define the minimal inhibitory concentration.
|
|
LPS binding.
The ability of ChBac5 and polymyxin B to bind
is shown in Fig. 8. Although polymyxin B
had a higher affinity for E. coli 0111:B4 LPS than did
ChBac5, the binding isotherm of ChBac5 was much steeper (Fig.
8a), consistent with positive cooperativity, an inference supported by
the Hill plot, which gave a slope of 2.56 for the data (Fig. 8b). We
did not test the ability of OaBac5 to bind LPS. More limited
experiments performed with OaBac5 revealed that this peptide also bound
LPS (data not shown).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 8.
LPS binding. The ability of ChBac5 and polymyxin B
to bind E. coli LPS in a quantitative chromogenic
Limulus assay. Note the different shapes of the binding
curves in panel a. Panel b is a Hill plot of the binding data. Hc, Hill
coefficient (slope).
|
|
 |
DISCUSSION |
Given the abundance of
-defensins in bovine neutrophils
(22), we were surprised to see the lack of defensins in
sheep and goat neutrophils (see Fig. 1). In this respect, ovine and
caprine neutrophils resemble those of pigs (10) and mice
(3), which also lack defensins. For the neutrophils of such
animals, cathelicidins may constitute the principal repository of
antimicrobial peptides, with
-defensins restricted to nonmyeloid
tissues, such as epithelia and glands.
OaBac5
and ChBac5 were highly active against gram-negative
bacteria (E. coli, S. typhimurium, and P. aeruginosa), exhibiting MICs of approximately 1 µg/ml under low
concentrations of salt. At 100 mM concentration NaCl had little effect
on their activities against E. coli and P. aeruginosa but reduced the efficacy of ChBac5 against S. typhimurium. Skerlavaj et al. reported that bovine Bac5 acted
optimally against E. coli under low-ionic-strength conditions (25) and speculated that the early interaction of bovine Bac5 with gram-negative target cells involved its electrostatic binding to negatively charged surface molecules, such as LPS. Bac5
molecules may retain their activity against gram-negative bacteria in
physiologic salt solutions by forming multiple hydrophobic interactions
between LPS and the apolar residues in the repeated tetrameric motif.
Gennaro et al. (6) performed microdilution assays to examine
the susceptibility of S. aureus, Staphylococcus
epidermidis, and Streptococcus agalactiae to bovine
Bac5 and reported that these gram-positive organisms were resistant to
that protein (MIC > 200 µg/ml). We also tested three
gram-positive organisms (S. aureus, L. monocytogenes, and B. subtilis) in the present
studies. All were highly susceptible to OaBac5 and ChBac5
under low concentrations of salt (MIC < 2 µg/ml), but S. aureus was highly resistant under high concentrations of salt (100 mM NaCl). Since the Mueller-Hinton and Iso-Sensitest broths used by
Gennaro et al. have high NaCl concentrations, our findings with
S. aureus are consistent with theirs.
Of the eight cathelicidin genes previously described in
sheep, four encoded the proline- and arginine-rich peptides designated OaBac5, OaBac6, OaBac7.5, and OaBac11 (9). The goat and
sheep Bac5 peptides described in this report were very similar to each other and resembled the previously described bovine Bac5 peptide. ChBac5 and OaBac5
contained 10 and 11 arginine residues,
respectively, and were highly cationic (pI > 13.0). They were
also unusually proline rich, because nearly their entire length
contained a repeated PPXR motif (with X representing an apolar amino
acid
phenylalanine, isoleucine, or valine). This tetrameric motif is
also found in bovine Bac5 (4).
Although we did not examine the structures or mechanisms of ovine and
caprine Bac5, such information exists from studies of bovine Bac5 and
related proline-rich antimicrobial peptides (14, 16, 28).
The repeating tetrapeptide motif of Bac5 (also found in the goat and
sheep peptides) assumes a polyproline II helical conformation when it
interacts with acidic phospholipids (14, 16), and residues 7 to 22 of Bac5 (highly conserved in the goat and sheep peptides) appear
to mediate its candidacidal activity (16). Gram-negative
bacteria treated with bovine Bac5 displayed rapid decreases in
respiration rate, transport, macromolecular syntheses, ATP content, and
membrane integrity (25).
Although the precursor of OaBac5 was previously delineated at the
nucleotide level (9), the corresponding peptide has not previously been purified and tested. While our experimental use of
elastase to process cathelicidin precursors in vitro could be
questioned, the in vitro-in vivo studies performed by Panyutich et al.
with porcine protegrins offer strong support for this approach (15). The mass spectrometric measurements of
elastase-generated ChBac5 indicate that its processing includes
C-terminal trimming and amidation
features found in several other
cathelin-associated antimicrobial peptides, including bovine
indolicidin and porcine PR-39 and prophenin. It is noteworthy that the
three residues (GKR) removed from the carboxy terminus of PR-39
propeptide when it is processed and amidated (see SwissProt accession
no. P80054) are very similar to the GRR residues removed from the
OaBac5 propeptide.
In summary, the present studies showed that Bac5 peptides from sheep or
goats bind LPS and kill gram-negative bacteria in concentrations of
NaCl similar to those found in extracellular fluids. Overall, these
findings suggest that Bac5 peptides may contribute substantially to
host defense against gram-negative bacterial infection in ruminants.
 |
ACKNOWLEDGMENTS |
This work was supported by National Institutes of Health grants
AI 22839 and AI 40248 and by Fogarty award TW00355.
We thank Gwen Laird, Yoon Cho, Jeffrey Turner, and Jean Laufer for
their expert technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, UCLA Center for the Health Sciences, 10833 LeConte Ave., Los Angeles, CA 90095-1690. Phone: (310) 825-5340. Fax: (310) 206-8766. E-mail: rlehrer{at}med1.medsch.ucla.edu.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Bagella, L.,
M. Scocchi, and M. Zanetti.
1995.
cDNA sequences of three sheep myeloid cathelicidins.
FEBS Lett.
376:225-228[Medline].
|
| 2.
|
Del Sal, G.,
P. Storici,
C. Schneider,
D. Romeo, and M. Zanetti.
1992.
cDNA cloning of the neutrophil bactericidal peptide indolicidin.
Biochem. Biophys. Res. Commun.
187:467-472[Medline].
|
| 3.
|
Eisenhauer, P. B., and R. I. Lehrer.
1992.
Mouse neutrophils lack defensins.
Infect. Immun.
60:3446-3447[Abstract/Free Full Text].
|
| 4.
|
Frank, R. W.,
G. Gennaro,
K. Schneider,
M. Przybylski, and D. Romeo.
1990.
Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils.
J. Biol. Chem.
265:18871-18874[Abstract/Free Full Text].
|
| 5.
|
Ganz, T., and J. Weiss.
1997.
Antimicrobial peptides of phagocytes and epithelia.
Semin. Hematol.
34:343-354[Medline].
|
| 6.
|
Gennaro, R.,
B. Skerlavaj, and D. Romeo.
1989.
Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.
Infect. Immun.
57:3142-3146[Abstract/Free Full Text].
|
| 7.
|
Gudmundsson, G. H.,
B. Agerberth,
J. Odeberg,
T. Bergman,
B. Olsson, and R. Salcedo.
1996.
The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.
Eur. J. Biochem.
238:325-332[Medline].
|
| 8.
|
Harwig, S. S. L.,
N. P. Chen,
A. S. K. Park, and R. I. Lehrer.
1993.
Purification of cysteine-rich bioactive peptides from leukocytes by continuous acid-urea polyacrylamide gel electrophoresis (CAU-PAGE).
Anal. Biochem.
208:382-386[Medline].
|
| 9.
|
Huttner, K. M.,
M. R. Lambeth,
H. R. Burkin,
D. J. Burkin, and T. E. Broad.
1998.
Localization and genomic organization of sheep antimicrobial peptide genes.
Gene
206:85-91[Medline].
|
| 10.
|
Kokryakov, V. N.,
S. S. L. Harwig,
E. A. Panyutich,
A. A. Shevchenko,
G. M. Aleshina,
O. V. Shamova,
H. A. Korneva, and R. I. Lehrer.
1993.
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.
FEBS Lett.
327:231-236[Medline].
|
| 11.
|
Lehrer, R. I.,
M. Rosenman,
S. S. L. Harwig,
R. Jackson, and P. Eisenhauer.
1991.
Ultrasensitive assays for endogenous antimicrobial polypeptides.
J. Immunol. Methods
137:167-173[Medline].
|
| 12.
|
Levy, O.
1996.
Antibiotic proteins of polymorphonuclear leukocytes.
Eur. J. Haematol.
56:263-277[Medline].
|
| 13.
|
Mahoney, M. M.,
A. Y. Lee,
D. J. Brezinski-Caliguri, and K. M. Huttner.
1995.
Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide.
FEBS Lett.
377:519-522[Medline].
|
| 14.
|
Niidome, T.,
H. Mihara,
M. Oka,
T. Hayashi,
T. Saiki,
K. Yoshida, and H. Aoyagi.
1998.
Structure and property of model peptides of proline/arginine-rich region in bactenecin 5.
J. Pept. Res.
51:337-345[Medline].
|
| 15.
|
Panyutich, A.,
J. Shi,
P. L. Boutz,
C. Zhao, and T. Ganz.
1997.
Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins.
Infect. Immun.
65:978-985[Abstract].
|
| 16.
|
Raj, P. A.,
E. Marcus, and M. Edgerton.
1996.
Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.
Biochemistry
35:526-530.
|
| 17.
|
Ritonja, A.,
M. Kopitar,
R. Jerala, and V. Turk.
1989.
Primary structure of a new cysteine proteinase inhibitor from pig leukocytes.
FEBS Lett.
255:211-214[Medline].
|
| 18.
|
Romeo, D.,
B. Skerlavaj,
M. Bolognesi, and R. Gennaro.
1988.
Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils.
J. Biol. Chem.
263:9573-9575[Abstract/Free Full Text].
|
| 19.
|
Scocchi, M.,
B. Skerlavaj,
D. Romeo, and R. Gennaro.
1992.
Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins.
Eur. J. Biochem.
209:589-595[Medline].
|
| 20.
|
Scocchi, M.,
S. Wang, and M. Zanetti.
1997.
Structural organization of the bovine cathelicidin gene family and identification of a novel member.
FEBS Lett.
417:311-315[Medline].
|
| 21.
|
Selsted, M. E.,
M. J. Novotny,
W. L. Morris,
Y. Q. Tang,
W. Smith, and J. S. Cullor.
1992.
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.
J. Biol. Chem.
267:4292-4295[Abstract/Free Full Text].
|
| 22.
|
Selsted, M. E.,
Y. Q. Tang,
W. L. Morris,
P. A. McGuire,
M. J. Novotny,
W. Smith,
A. H. Henschen, and J. S. Cullor.
1993.
Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.
J. Biol. Chem.
268:6641-6648[Abstract/Free Full Text].
|
| 23.
|
Shi, J., and T. Ganz.
1998.
The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids.
Infect. Immun.
66:3611-3617[Abstract/Free Full Text].
|
| 24.
|
Skerlavaj, B.,
R. Gennaro,
L. Bagella,
L. Merluzzi,
A. Risso, and M. Zanetti.
1996.
Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.
J. Biol. Chem.
271:28375-28381[Abstract/Free Full Text].
|
| 25.
|
Skerlavaj, B.,
D. Romeo, and R. Gennaro.
1990.
Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins.
Infect. Immun.
58:3724-3730[Abstract/Free Full Text].
|
| 26.
|
Sorensen, O.,
K. Arnljots,
J. B. Cowland,
D. F. Bainton, and N. Borregaard.
1997.
The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils.
Blood
90:2796-2803[Abstract/Free Full Text].
|
| 27.
|
Steinberg, D., and R. I. Lehrer.
1997.
Designer assays for antimicrobial peptides: disputing the "one size fits all" theory, p. 169-187.
In
W. M. Shafer (ed.), Methods in molecular biology. Humana Press, Totowa, N.J.
|
| 28.
|
Tani, A.,
S. Lee,
O. Oishi,
H. Aoyagi, and M. Ohno.
1995.
Interaction of the fragments characteristic of bactenecin 7 with phospholipid bilayers and their antimicrobial activity.
J. Biochem.
117:560-565[Abstract/Free Full Text].
|
| 29.
|
Tossi, A.,
M. Scocchi,
M. Zanetti,
P. Storici, and R. Gennaro.
1995.
PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity.
Eur. J. Biochem.
228:941-946[Medline].
|
| 30.
|
Turner, J.,
Y. Cho,
N. N. Dinh,
A. J. Waring, and R. I. Lehrer.
1998.
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
Antimicrob. Agents Chemother.
42:2206-2214[Abstract/Free Full Text].
|
| 31.
|
Zanetti, M.,
R. Gennaro, and D. Romeo.
1995.
Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.
FEBS Lett.
374:1-5[Medline].
|
| 32.
|
Zanetti, M.,
L. Litteri,
G. Griffiths,
R. Gennaro, and D. Romeo.
1991.
Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides.
J. Immunol.
146:4295-4300[Abstract].
|
Infection and Immunity, August 1999, p. 4106-4111, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chang, C.-I, Zhang, Y.-A., Zou, J., Nie, P., Secombes, C. J.
(2006). Two Cathelicidin Genes Are Present in both Rainbow Trout (Oncorhynchus mykiss) and Atlantic Salmon (Salmo salar). Antimicrob. Agents Chemother.
50: 185-195
[Abstract]
[Full Text]
-
Anderson, R. C., Hancock, R. E. W., Yu, P.-L.
(2004). Antimicrobial Activity and Bacterial-Membrane Interaction of Ovine-Derived Cathelicidins. Antimicrob. Agents Chemother.
48: 673-676
[Abstract]
[Full Text]
-
Zanetti, M.
(2004). Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol.
75: 39-48
[Abstract]
[Full Text]
-
Zhao, C., Nguyen, T., Boo, L. M., Hong, T., Espiritu, C., Orlov, D., Wang, W., Waring, A., Lehrer, R. I.
(2001). RL-37, an Alpha-Helical Antimicrobial Peptide of the Rhesus Monkey. Antimicrob. Agents Chemother.
45: 2695-2702
[Abstract]
[Full Text]
-
Wu, H., Zhang, G., Minton, J. E., Ross, C. R., Blecha, F.
(2000). Regulation of Cathelicidin Gene Expression: Induction by Lipopolysaccharide, Interleukin-6, Retinoic Acid, and Salmonella enterica Serovar Typhimurium Infection. Infect. Immun.
68: 5552-5558
[Abstract]
[Full Text]